Peru: Market and regulatory data analysis of the cannabis sector

6th March 2023: Peru: The Ministry of Health has approved Resolution 004-2023 on the medicinal use of cannabis, which sets further conditions and licence requirements for the commercial or non-commercial cultivation and import of medical cannabis. The regulation also establishes the creation of an importer/retailer registry to be under the control of the Directorate-General of Medicines, Supplies and Drugs (Digemid). Under the regulation, the Ministry of Health has 90 days to launch the registry.
2nd June 2022: Peru: The Ministry of Health has published a draft bill on the medicinal use of cannabis. The bill is now subject to a public consultation period, in which stakeholders or any person interested in the bill can submit questions and proposals to webmaster@minsa.gob.pe. The consultation period started on 16th May and will be ongoing for 90 days. Once that period is concluded, the final draft of the bill will be published. The bill is aimed at regulating in more detail Law 30681 on the use of medical cannabis. This current version of the bill proposes to establish further conditions and licences for the commercial or non-commercial cultivation and import of cannabis. It also proposes the creation of a patient registry and an importer/retailer registry, and establishes as mandatory the possession of a special medical prescription in order to access medical cannabis with a THC content above 1%.

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis

Cannabis and cannabinoids in Peru